Conventus Orthopaedics
- Company typePrivate
- Founded2008
- HeadquartersMaple Grove, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Conventus Orthopaedics does
Conventus Orthopaedics is a privately held US orthopedic medical device company that designs, manufactures, and sells specialty implants and sterile surgical solutions for fracture fixation and ligament repair. Founded in 2008 and headquartered in Maple Grove, Minnesota, the company built its identity around the FlexThread intramedullary nail platform, whose flexible-shaft design enables minimally invasive treatment of distal fibula and ulna fractures and osteotomies while accepting both flexible and rigid syndesmotic fixation. In May 2020, Conventus acquired Flower Orthopedics (Horsham, Pennsylvania), and the combined business now operates as Conventus Flower Orthopedics, a DBA of Flower Orthopedics Corporation, extending the portfolio to include the Constrictor knotless adjustable-button syndesmosis repair system, Ready-For-Surgery prepackaged sterile implant-and-instrument kits, plates, screws, and a biologics line.
The company sells exclusively through a direct enterprise field-sales motion targeting US orthopedic surgeons, hospital procurement teams, and surgical centers. Its revenue model is hardware sales of Class II/III orthopedic implants and consumables, with no disclosed pricing transparency beyond quote-based engagement through sales representatives. Customer-facing differentiators center on the FlexThread flexible nail architecture, claimed superior cyclic-loading and ultimate failure-to-load performance of the Constrictor versus the market leader, and the workflow efficiency of Ready-For-Surgery customizable sterile kits that reduce operating-room preparation time.
Operationally, Conventus has raised approximately $176M across ten funding rounds from 2013 through May 2020, with notable institutional participation from Deerfield Capital Management, Ally Bridge Group, BioStar Capital, Blue Sky Fund, Bluestem Capital, SightLine Partners, Oxford Finance, and Square 1 Bank. Headcount is reported in the 11-50 range. Leadership includes co-founder and CTO Paul Hindrichs, Executive Chairman Rick Epstein, CFO Jonathan Isenburg, VP of Marketing Tracy Martellotta, and VP of R&D and Operations Mike Mazzio. No public revenue, customer concentration, or geographic expansion data is disclosed.
Conventus Orthopaedics firmographics
Firmographics- Name
- Conventus Orthopaedics
- Legal name
- Flower Orthopedics Corporation
- Website
- https://conventusortho.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Conventus Orthopaedics industry classification
Industry- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB)
Keywords
Where Conventus Orthopaedics is headquartered
LocationHeadquarters
- HQ city
- Maple Grove
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Conventus Orthopaedics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure
Revenue model
- Orthopedic implant and surgical device sales: Sale of intramedullary nails, syndesmosis repair systems, plates, screws, and biologics to healthcare providers and surgical centers. Revenue generated through direct sales of medical devices and surgical implants.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Conventus Orthopaedics product offering
Product offeringCore offering
Conventus Orthopaedics (operating as Conventus Flower Orthopedics via Flower Orthopedics Corporation) designs, manufactures, and sells orthopedic surgical implants and fixation devices, including the FlexThread® intramedullary nail platform for fibula and ulna fractures, the Constrictor® knotless syndesmosis repair system for ankle ligament disruptions, and Ready-For-Surgery® prepackaged sterile implant and instrument kits. The company sells directly to orthopedic surgeons, hospitals, and surgical centers.
Product overview
Conventus Flower Orthopedics offers a portfolio of innovative orthopedic implant solutions organized around two core product lines: the FlexThread® IM Nail Platform (including Flex-Thread® Distal Fibula and Ulna Intramedullary Nails) for minimally invasive fracture treatment with flexible nail technology, and the Constrictor® Rope Syndesmosis Repair system for ankle ligament repair. These are complemented by the Ready-For-Surgery® Solutions line, which provides prepackaged, sterile-packaged plates, screws, and biologics for surgical procedures, enabling operating room efficiency with all required implants and instruments ready for use in standard or customizable configurations.
Differentiator
Problem solved
Functional benefit
Brands
- FlexThread®: Intramedullary nail platform for treatment of fibula and ulna fractures and osteotomies
- Constrictor®
- Ready-For-Surgery®
Quantifiable outcome
- Superior fixation under cyclic loading vs market leader (Constrictor)
- +1 more outcomes
Companies that use Conventus Orthopaedics
Customer profileSegments2 records
Conventus Orthopaedics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Conventus Orthopaedics partnerships and signals
Strategic signalRecent moves6 records
Expansion highlights4 records
Conventus Orthopaedics competitors and assessment
Company assessmentDirect peers
- Arthrex: Arthrex is the dominant player in sports medicine and extremity soft-tissue fixation. Its TightRope system is the cited 'market leader' in ankle syndesmosis repair — the exact competitive frame Conventus Flower's Constrictor is built to disrupt.
- Acumed: Acumed specializes in upper and lower extremity implants, including small-bone intramedullary nails and foot/ankle fixation. It is the most direct US-based comparable for the FlexThread distal fibula/ulna nail platform.
- Orthofix Medical: Orthofix is a focused extremity and spine orthopedic device company selling plates, screws, nails and biologics through a direct sales force. Its portfolio breadth in extremity trauma and biologics closely mirrors Conventus Flower's bundled offering.
- Paragon 28: Paragon 28 is a foot-and-ankle-focused orthopedic company with a sterile-pack / single-use instrumentation model that mirrors Conventus Flower's Ready-For-Surgery approach. It is a relevant direct comparable on both indication and packaging innovation.
Broad incumbents
- Stryker: Stryker is one of the largest orthopedic trauma and extremities competitors globally, with deep surgeon relationships, broad product breadth and the marketing/sales scale to rapidly neutralize niche entrants like Conventus Flower.
- Smith+Nephew: Smith+Nephew's Trauma & Extremities business competes across plates, screws, IM nails and ankle fixation. It is one of the major incumbents whose portfolio overlap and rep coverage set the competitive floor for Conventus Flower's commercial efforts.
- DePuy Synthes (Johnson & Johnson): DePuy Synthes is the historical category leader in orthopedic trauma, including IM nails and plates/screws. Its installed base, surgeon training programs and IDN contracts represent the biggest barrier to Conventus Flower's penetration of large hospital systems.
- Integra LifeSciences: Integra's Orthopedics and Tissue Technologies segment sells extremity fixation hardware and biologics through specialty channels. Its extremity focus and biologics overlap with Conventus Flower's portfolio make it a comparable mid-size peer.
- Enovis (DJO): Enovis, via DJO Surgical and its extremities portfolio, sells orthopedic implants including plates, screws and specialty fixation devices. Its broader portfolio and global reach make it a relevant comparable for Conventus Flower's commercial scaling trajectory.
Emerging players
- Treace Medical Concepts: Treace is an emerging foot-and-ankle-focused orthopedic company with proprietary implants and a direct sales model targeting a narrow set of indications — a useful comparison point on go-to-market and indication-narrow growth dynamics.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Conventus Orthopaedics social profiles
Digital presenceConventus Orthopaedics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Conventus Orthopaedics leadership team
Management profileNumber of profiles
Conventus Orthopaedics funding detail
Funding detailFunding overview
Funding rounds10 records
Investors12 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Conventus Orthopaedics M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Conventus Orthopaedics
What does Conventus Orthopaedics do?
Conventus Orthopaedics (operating as Conventus Flower Orthopedics via Flower Orthopedics Corporation) designs, manufactures, and sells orthopedic surgical implants and fixation devices, including the FlexThread® intramedullary nail platform for fibula and ulna fractures, the Constrictor® knotless syndesmosis repair system for ankle ligament disruptions, and Ready-For-Surgery® prepackaged sterile implant and instrument kits. The company sells directly to orthopedic surgeons, hospitals, and surgical centers.
Is Conventus Orthopaedics a public or private company?
Conventus Orthopaedics is a private company. It is classified as venture growth investor backed and is currently operating.
When was Conventus Orthopaedics founded?
Conventus Orthopaedics was founded in 2008. It employs 11 to 50 people.
Where is Conventus Orthopaedics based?
Conventus Orthopaedics is headquartered in Maple Grove, United States, in the North America region.
How does Conventus Orthopaedics make money?
One revenue line is on record: orthopedic implant and surgical device sales.
Who are Conventus Orthopaedics's main competitors?
Direct peers on record are Arthrex, Acumed, Orthofix Medical and Paragon 28. Broad incumbents are Stryker, Smith+Nephew, DePuy Synthes (Johnson & Johnson), Integra LifeSciences and Enovis (DJO). Treace Medical Concepts is listed as an emerging player.
Does Conventus Orthopaedics have an API?
No public API is recorded for Conventus Orthopaedics.
What industry is Conventus Orthopaedics in?
Its primary akta.pro industry code is HLAHAEAB, Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation). Its NAICS code is 339113 and its SIC code is 3842.